Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs

…, P Dewachter, M Dilley, JR Farmer, D Foer… - The Journal of Allergy …, 2020 - Elsevier
Allergists and clinical immunologists around the world are increasingly faced with the task
of addressing drug allergy and hypersensitivity due to the increase in drug reactions. …

Asthma exacerbations in patients with type 2 diabetes and asthma on glucagon-like peptide-1 receptor agonists

D Foer, PE Beeler, J Cui, EW Karlson… - American journal of …, 2021 - atsjournals.org
Rationale: GLP-1R (glucagon-like peptide-1 receptor) agonists are approved to treat type 2
diabetes mellitus and obesity. GLP-1R agonists reduce airway inflammation and …

[HTML][HTML] Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review

A Syrowatka, W Song, MG Amato, D Foer… - The Lancet Digital …, 2022 - thelancet.com
Adverse drug events (ADEs) represent one of the most prevalent types of health-care-related
harm, and there is substantial room for improvement in the way that they are currently …

[HTML][HTML] PASCLex: A comprehensive post-acute sequelae of COVID-19 (PASC) symptom lexicon derived from electronic health record clinical notes

L Wang, D Foer, E MacPhaul, YC Lo, DW Bates… - Journal of Biomedical …, 2022 - Elsevier
Objective To develop a comprehensive post-acute sequelae of COVID-19 (PASC) symptom
lexicon (PASCLex) from clinical notes to support PASC symptom identification and research. …

Progestogen hypersensitivity in 24 cases: diagnosis, management, and proposed renaming and classification

D Foer, KM Buchheit, AR Gargiulo, DM Lynch… - The Journal of Allergy …, 2016 - Elsevier
Background Autoimmune progesterone dermatitis is a poorly recognized syndrome associated
with a hypersensitivity to progestogens. Symptoms present heterogeneously, which may …

Association of GLP-1 Receptor Agonists with Chronic Obstructive Pulmonary Disease Exacerbations among Patients with Type 2 Diabetes

D Foer, ZH Strasser, J Cui, KN Cahill… - American Journal of …, 2023 - atsjournals.org
Rationale: Patients with chronic obstructive pulmonary disease (COPD) and type 2 diabetes
(T2D) have worse clinical outcomes compared with patients without metabolic dysregulation…

To the hospital and back home again: a nurse practitioner‐based transitional care program for hospitalized homebound people

K Ornstein, KL Smith, DH Foer… - Journal of the …, 2011 - Wiley Online Library
Homebound older adults may receive suboptimal care during hospitalizations and
transitions home or to postacute settings. This 2‐year study describes a nurse practitioner (NP)‐led …

Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19

L Wang, D Foer, DW Bates, JA Boyce… - Journal of Allergy and …, 2020 - jacionline.org
This case series used data (March 3, 2020, to June 8, 2020) from the Massachusetts-based
Mass General Brigham (MGB, formerly Partners HealthCare) health system’s electronic …

A deep learning approach for transgender and gender diverse patient identification in electronic health records

…, A McDowell, DW Bates, D Foer… - Journal of Biomedical …, 2023 - Elsevier
Background Although accurate identification of gender identity in the electronic health record
(EHR) is crucial for providing equitable health care, particularly for transgender and gender …

User-centered design of a scalable, electronic health record-integrated remote symptom monitoring intervention for patients with asthma and providers in primary care

…, J Sousa, S Plombon, A Arcia, D Foer… - Journal of the …, 2021 - academic.oup.com
Objective To determine user and electronic health records (EHR) integration requirements
for a scalable remote symptom monitoring intervention for asthma patients and their providers…